HI-Bio Secures $95 Million in Series B Financing to Propel Targeted Therapies for Immune-Mediated Diseases January 8, 2024
OnCusp Therapeutics Secures $100 Million in Oversubscribed Series A Funding to Propel Cancer Treatment Innovations January 8, 2024
Revagenix Raised Series B Financing to Advance Novel Antibiotics and Strengthens Board with Industry Experts January 8, 2024
Hatz AI Secures $2.5M Seed Funding Led by Vestigo Ventures to Empower MSPs in Delivering AI-as-a-Service January 8, 2024
Paris-Based AI Startup Nabla Secures $24M Series B to Propel US Expansion of AI-Powered Clinical Note Tool January 8, 2024
Knownwell Secures $2 Million in Pre-seed Funding for Revolutionary Intelligent Enterprise Operating System January 4, 2024